The Longevity Bloodwork Panel: 12 Biomarkers Every Man Over 40 Should Know
The Longevity Bloodwork Panel: 12 Biomarkers Every Man Over 40 Should Know
Medically reviewed by the Live Forever Health clinical team · Updated April 2026 · 11 min read
Your annual physical is not a longevity evaluation. It is a disease screening. Those are different things — and the difference matters enormously once you pass 40 and the trajectory of your biological aging becomes something you can actually measure, track, and influence.
The standard blood work ordered at a typical annual physical is designed to catch established disease. It will identify diabetes when blood sugar has been elevated for years, flag cardiovascular risk once cholesterol has been problematic for a decade, and detect thyroid dysfunction after it has been suppressing your metabolism long enough to move a single number outside a wide reference range. By the time these markers move, the underlying processes have often been running for years.
Longevity medicine operates on a different principle: identify the biological risk factors and aging mechanisms before they become diagnosed conditions — early enough that targeted intervention can change the trajectory rather than simply manage the damage. This requires a different panel. Not more tests for the sake of more tests, but specific biomarkers that reflect the processes that actually drive aging, disease risk, and functional decline in men over 40.
This article covers the 12 most clinically important biomarkers for men's longevity — what each one measures, what optimal looks like for a man over 40 (not just 'normal' for a broad population), what the evidence says about its connection to aging and disease risk, and what to do when it is out of range. By the end, you will understand not just what to test, but why each number matters and what it reveals about how your body is actually aging.
Why 'Normal' Is Not the Same as Optimal
Before we walk through the biomarkers, one foundational concept needs to be established: the difference between a reference range and an optimal range. This distinction is one of the most important — and most consistently misunderstood — aspects of preventive medicine.
Standard laboratory reference ranges are built by testing a large population sample and identifying the range within which 95 percent of values fall. This means that by definition, 5 percent of completely healthy individuals fall outside the range at any given time. More importantly, it means that the reference range includes everyone in the sample population — including those who are sick, sedentary, metabolically dysfunctional, and aging poorly. 'Normal' is the average of a population that is itself not particularly healthy.
Optimal is different. Optimal means the level at which the biomarker is associated with the lowest disease risk and the best long-term health outcomes — based on outcomes research rather than population distribution. For many of the biomarkers in this article, the optimal range is meaningfully narrower and better than the standard reference range. A man told his results are 'all normal' may have several markers that are normal but not optimal — sitting in ranges associated with elevated long-term risk that a standard interpretation would never flag.
The Key Clinical Distinction
When your physician says your results are 'normal,' they mean your values fall within the population reference range — which is not the same as optimal for longevity. Longevity medicine targets the ranges associated with the best outcomes in outcomes research: often narrower, often more stringent, and almost always more clinically meaningful than the broad ranges printed on a standard lab report.
The 12 Biomarkers: Complete Reference Guide
The table below provides a comprehensive reference for each of the 12 biomarkers most important for men's longevity — including standard ranges, optimal targets for men over 40, why each marker matters for aging specifically, and the first-line intervention when a value is off.
| # | BIOMARKER | CATEGORY | STANDARD RANGE | OPTIMAL TARGET (MEN 40+) | WHY IT MATTERS FOR LONGEVITY | ACTION IF OFF |
|---|---|---|---|---|---|---|
| 1 | Free & Total Testosterone | Hormonal | 300–1,000 ng/dL (total) | 600–900 ng/dL total; free T in upper quartile for age | Drives muscle maintenance, cognitive function, insulin sensitivity, bone density, and cardiovascular health. Decline accelerates virtually every aging pathway in men. | Hormone evaluation; TRT if symptomatic and deficient |
| 2 | hs-CRP (High-Sensitivity C-Reactive Protein) | Inflammation | < 3.0 mg/L (general) | < 1.0 mg/L | The primary marker of systemic low-grade inflammation — the central driver of cardiovascular disease, metabolic syndrome, cognitive decline, and accelerated biological aging (inflammaging). | Anti-inflammatory diet; address metabolic root causes; omega-3 supplementation |
| 3 | HbA1c (Glycated Hemoglobin) | Metabolic | < 5.7% | < 5.4% | Reflects 3-month average blood glucose. Glycation — the binding of sugar to proteins — damages blood vessels, nerves, and DNA. One of the most direct measurable mechanisms of accelerated aging. | Dietary glycemic management; time-restricted eating; metformin if pre-diabetic; GLP-1 therapy |
| 4 | Fasting Insulin | Metabolic | 2–25 µIU/mL (wide range) | < 8 µIU/mL fasting | Elevated fasting insulin is the earliest detectable sign of insulin resistance — often present years before HbA1c or glucose become abnormal. Hyperinsulinemia directly promotes fat storage, vascular damage, and tumor growth. | Low-glycemic diet; resistance training; reduce refined carbohydrates; consider metformin |
| 5 | ApoB (Apolipoprotein B) | Cardiovascular | < 130 mg/dL | < 80 mg/dL (< 70 if high-risk) | ApoB directly counts the number of atherogenic particles in the blood — each LDL, VLDL, and IDL particle carries one ApoB molecule. This is a far stronger predictor of cardiovascular events than LDL cholesterol alone. | Dietary fat quality; statin or PCSK9 inhibitor if elevated; lifestyle optimization |
| 6 | Homocysteine | Cardiovascular / Neurological | < 15 µmol/L (general) | < 9 µmol/L | Elevated homocysteine independently damages arterial walls and is one of the strongest modifiable predictors of cardiovascular disease, stroke, and dementia. Also a direct epigenetic aging accelerant — it disrupts the methylation pathways that regulate DNA. | Methylated B vitamins (B6, B12, folate); address MTHFR variants; dietary protein quality |
| 7 | Free T3 & TSH (Thyroid Panel) | Hormonal / Metabolic | TSH: 0.4–4.5 mIU/L | TSH: 1.0–2.5 mIU/L; Free T3 in upper half of range | Thyroid hormones regulate metabolic rate, body temperature, heart rate, and cellular energy production. Subclinical hypothyroidism — normal TSH but suboptimal T3 — produces fatigue, weight gain, cognitive fog, and lipid abnormalities without triggering standard diagnosis. | Full thyroid panel including free T3 and T4; consider optimization if symptomatic with borderline labs |
| 8 | Vitamin D (25-OH) | Immune / Metabolic | 20–50 ng/mL | > 50 ng/mL (ideally 60–80 ng/mL) | Vitamin D functions as a hormone, not just a vitamin. Deficiency is linked to immune dysfunction, depression, accelerated biological aging, cardiovascular risk, insulin resistance, and significantly increased all-cause mortality in multiple large-scale studies. | D3 + K2 supplementation (5,000–10,000 IU D3/day with K2); retest in 90 days; sun exposure |
| 9 | IGF-1 (Insulin-Like Growth Factor 1) | Hormonal / Repair | Age-dependent (broad range) | Upper quartile for age — typically 150–250 ng/mL at 40–60 | IGF-1 reflects growth hormone output and governs the body's cellular repair and regeneration capacity. Declining IGF-1 after age 30 is a key driver of reduced muscle maintenance, impaired recovery, increased frailty, and accelerated biological aging. | Resistance training; sleep optimization; consider peptide therapy (Sermorelin, CJC-1295); reduce visceral fat |
| 10 | DHEA-S (Dehydroepiandrosterone Sulfate) | Hormonal | Age-dependent (declines sharply) | Upper third of age-adjusted range; equivalent to a younger reference range | DHEA-S is the most abundant steroid hormone in the body and one of the most reliable markers of adrenal reserve and overall hormonal vitality. Its decline tracks closely with biological aging and is associated with increased cardiovascular risk, immune senescence, and reduced stress resilience. | DHEA supplementation (25–50mg/day); stress reduction; sleep optimization; address cortisol excess |
| 11 | Omega-3 Index (EPA + DHA) | Cellular / Cardiovascular | Low: < 4%; Average: 4–8% | > 8% (ideally > 10%) | The omega-3 index measures the percentage of EPA and DHA in red blood cell membranes — a direct reflection of cellular membrane health. Low omega-3 index is one of the strongest modifiable predictors of cardiovascular mortality, cognitive decline, and accelerated cellular aging. | High-dose fish oil or algae-based omega-3 (2–4g EPA+DHA daily); retest in 90–120 days |
| 12 | Ferritin | Iron Metabolism / Inflammation | 12–300 ng/mL (men) | 30–150 ng/mL | Both very low and very high ferritin are clinically significant. Low ferritin indicates iron deficiency affecting energy and cognitive function. Elevated ferritin — particularly above 200 in men — is an independent marker of inflammation, liver stress, and metabolic dysfunction, and is associated with accelerated oxidative damage. | If low: dietary iron and possible supplementation. If high: investigate inflammatory cause; consider therapeutic phlebotomy; reduce alcohol |
The Clinical Story Behind Each Biomarker
The table gives you the reference data. This section gives you the clinical reasoning — why each marker matters specifically for men over 40, what its trajectory looks like as the body ages, and what it tells you that other markers do not.
1. Testosterone: The Master Regulator You Cannot Afford to Ignore
Testosterone is not just a sex hormone. It is a systemic regulator of metabolic health, cardiovascular function, cognitive performance, and body composition. After age 30, total testosterone declines at approximately 1 to 2 percent per year — a slow enough rate that many men do not notice the change until it has been accumulating for a decade. By 45, a significant proportion of men have testosterone levels that would have been flagged as deficient at 25.
What makes testosterone particularly important as a longevity biomarker is the breadth of downstream effects its decline produces. Low testosterone is independently associated with insulin resistance, visceral fat accumulation, reduced bone density, cognitive decline, depression, impaired sleep architecture, and elevated cardiovascular risk. These are not separate conditions — they are the systemic consequences of a single hormonal decline that standard preventive medicine often does not prioritize measuring until symptoms are severe.
For men over 40, total testosterone alone is insufficient. Free testosterone — the biologically active fraction not bound to SHBG — is equally important and often more clinically relevant. A man with total testosterone of 550 ng/dL and very high SHBG may have free testosterone in a range that produces symptomatic deficiency. Testing both, alongside SHBG and estradiol, is the minimum standard for a meaningful hormonal evaluation.
2 & 3. hs-CRP and HbA1c: The Twin Pillars of Metabolic Aging
Chronic low-grade inflammation and glycemic dysfunction are the two most pervasive mechanisms of biological aging in modern men — and they are deeply interconnected. Elevated hs-CRP reflects the systemic inflammatory state that drives atherosclerosis, neurodegeneration, insulin resistance, and cellular senescence. Elevated HbA1c reflects the glycation of proteins that damages blood vessels, nerves, and DNA with the biochemical efficiency of slow corrosion.
The critical insight for men over 40 is that both of these markers begin shifting meaningfully in the 30s and 40s — often years before any clinical diagnosis is triggered. A man with hs-CRP of 1.8 mg/L is not 'normal' from a longevity standpoint; he is in a range associated with approximately twice the cardiovascular risk of a man under 0.5 mg/L. A man with HbA1c of 5.6 percent is technically pre-pre-diabetic, but the glycation damage has already been accumulating for years. The standard thresholds for intervention are set at diagnosis, not at optimal prevention.
4. Fasting Insulin: The Earliest Warning Sign Nobody Orders
Of all the biomarkers in this panel, fasting insulin may be the most underappreciated gap in standard preventive care. Insulin resistance — the cellular inability to respond normally to insulin — is the metabolic root cause behind type 2 diabetes, metabolic syndrome, PCOS, non-alcoholic fatty liver disease, and a significant proportion of cardiovascular disease. And it is detectable through elevated fasting insulin years to decades before fasting glucose or HbA1c become abnormal.
The reason fasting insulin is rarely ordered in standard care is partly convention and partly the absence of an established diagnostic threshold in major guidelines. But the research is clear: fasting insulin above 8 to 10 µIU/mL in a fasting state reflects meaningful insulin resistance, even when glucose is completely normal. For men over 40 with abdominal fat, fatigue, cravings for carbohydrates, or difficulty losing weight despite reasonable diet, fasting insulin is frequently the explanatory variable that was never measured.
5. ApoB: The Cardiovascular Marker That Outperforms LDL
The shift from LDL cholesterol to ApoB as the primary cardiovascular risk metric is one of the most significant developments in preventive cardiology of the past decade — and it has been slow to reach standard clinical practice. LDL cholesterol measures the mass of cholesterol in LDL particles. ApoB measures the number of those particles — each one capable of penetrating arterial walls and initiating atherogenesis, regardless of how much cholesterol it contains.
The practical consequence of this distinction is that men with small, dense LDL particles — a pattern associated with insulin resistance and metabolic syndrome — can have a 'normal' LDL cholesterol while carrying a significantly elevated number of atherogenic particles. ApoB catches this. LDL does not. Research consistently shows that ApoB is a stronger predictor of major cardiovascular events than LDL cholesterol, including in men who are already on statin therapy. It should be a standard component of any men's health panel after 40.
6. Homocysteine: The Vascular and Cognitive Risk Factor That Is Easily Fixed
Homocysteine is an amino acid produced as a byproduct of methionine metabolism. When it accumulates — due to inadequate B vitamin cofactors, genetic variants in the MTHFR enzyme, or poor diet — it damages arterial endothelium directly, impairs nitric oxide production, and disrupts the methylation chemistry that regulates DNA expression and epigenetic aging.
The evidence linking elevated homocysteine to cardiovascular disease and dementia is among the most robust in preventive medicine. A 1997 meta-analysis in JAMA covering more than 4,000 patients found that homocysteine above 10 µmol/L was independently associated with a 60 percent increased risk of coronary artery disease. More recent research has established homocysteine as one of the strongest modifiable predictors of Alzheimer's disease risk. And the treatment is simple: methylated B vitamins (specifically methylfolate, methylcobalamin, and P-5-P) normalize homocysteine in the majority of cases within 90 days. This is a high-impact intervention that requires a $15 test to identify and $20 per month to treat.
7. Free T3 and TSH: Why Thyroid Testing Needs an Upgrade
TSH — thyroid-stimulating hormone — is the standard thyroid screening marker in virtually all primary care settings. It measures how hard the pituitary is working to stimulate the thyroid. But it does not directly measure the active thyroid hormone at the cellular level — that is free T3, the form of thyroid hormone that enters cells and drives metabolic rate, body temperature, and energy production.
A man can have a normal TSH and meaningfully impaired cellular thyroid function if his body is not efficiently converting T4 (the storage form) to T3 (the active form). This pattern — sometimes called subclinical hypothyroidism or low T3 syndrome — produces classic hypothyroid symptoms: persistent fatigue, difficulty losing weight, cold intolerance, brain fog, and elevated LDL cholesterol. It will never be identified by TSH alone. Free T3 testing is essential for any man over 40 with these symptoms and a 'normal' TSH.
8 & 11. Vitamin D and Omega-3 Index: The Two Most Correctable Aging Risk Factors
If there is a hierarchy of interventional value among the 12 biomarkers in this panel, vitamin D and the omega-3 index sit near the top — not because they are the most predictive of aging, but because deficiency is extraordinarily common, the downstream health consequences are broad and well-documented, and correction is straightforward and inexpensive.
An estimated 40 to 60 percent of American adults are vitamin D deficient, with levels below 20 ng/mL. Even more fall short of the optimal range for longevity purposes (above 50 ng/mL). Vitamin D deficiency is independently associated with increased all-cause mortality, immune dysfunction, depression, cardiovascular disease, insulin resistance, and accelerated epigenetic aging. Correcting it with D3 and K2 supplementation is safe, affordable, and produces measurable improvements in multiple downstream markers within 90 days.
The omega-3 index is less commonly tested but equally important. Red blood cell EPA and DHA content below 4 percent is associated with significantly elevated cardiovascular mortality risk. Above 8 percent, the risk is substantially reduced. The majority of Americans fall in the 4 to 6 percent range — a zone of elevated risk that a standard lipid panel does not capture. High-dose EPA/DHA supplementation consistently moves the omega-3 index into the protective range within three to four months.
9 & 10. IGF-1 and DHEA-S: The Hormonal Aging Clocks
Both IGF-1 and DHEA-S decline predictably and substantially with age — and both reflect fundamental aspects of the body's capacity to repair, maintain, and protect itself against the cumulative damage of aging.
IGF-1 peaks in adolescence and declines throughout adulthood, reaching roughly half its peak value by the early 60s in most men. It governs the cellular repair and regeneration capacity that determines how well the body recovers from training, illness, stress, and daily cellular damage. Optimizing IGF-1 — through resistance training, sleep quality, reduced visceral fat, and where appropriate, peptide therapies — is one of the interventions with the most direct evidence for supporting healthy aging trajectories.
DHEA-S follows a similar declining trajectory. It is the most abundant circulating steroid hormone in the human body and a precursor to both testosterone and estrogen. Its decline tracks reliably with chronological aging and is associated with increased inflammatory markers, immune senescence, reduced stress resilience, and elevated cardiovascular risk. DHEA supplementation in deficient individuals has demonstrated improvements in mood, energy, immune function, and cardiovascular markers in multiple clinical trials — at a cost of roughly $20 per month.
12. Ferritin: The Marker That Can Mean Two Completely Opposite Things
Ferritin is unusual in this panel because its interpretation depends entirely on where it falls relative to the optimal range — and the concern is different at each end. Low ferritin (below 30 ng/mL in men) indicates iron deficiency even when hemoglobin is normal, producing fatigue, cognitive impairment, reduced athletic performance, and impaired immune function. Many men with iron deficiency are never identified because their hemoglobin remains technically normal while their ferritin — the more sensitive indicator — has been suppressed for months.
Elevated ferritin (above 200 ng/mL in men) is a different clinical situation entirely. High ferritin is an acute-phase reactant — it rises in response to inflammation, liver disease, metabolic syndrome, and excess alcohol intake. Chronically elevated ferritin is associated with accelerated oxidative stress, because excess iron catalyzes the production of free radicals. Men with ferritin above 200 should have the cause investigated, not simply reassured that their levels are 'within range.'
"The annual physical tells a man whether he has a disease today. The longevity panel tells him where his biology is heading and what can be done about it before the destination is reached. That's the difference between reactive medicine and the kind of proactive, data-driven health management that actually changes outcomes over a lifetime."
— Live Forever Health Clinical Team
What Your Annual Physical Is Missing — And Why It Matters
To make the gap between standard preventive care and longevity medicine concrete, here is a direct comparison of which longevity-critical biomarkers are and are not included in a standard annual physical panel:
| BIOMARKER | INCLUDED IN STANDARD PHYSICAL? | WHAT YOU MISS WITHOUT IT |
|---|---|---|
| Free Testosterone | ❌ Rarely | Total testosterone alone misses the biologically active fraction. A man can have adequate total T but severely low free T due to elevated SHBG — and remain symptomatic with a 'normal' result. |
| hs-CRP | ❌ No | Standard CRP is too insensitive for low-grade chronic inflammation detection. hs-CRP is the clinically validated version. Most annual physicals skip it entirely. |
| ApoB | ❌ Rarely | Standard lipid panels report LDL cholesterol — a measure of cholesterol mass, not particle number. ApoB counts actual atherogenic particles and is a far stronger cardiovascular risk predictor. Many men with 'good cholesterol' have elevated ApoB. |
| Fasting Insulin | ❌ Almost never | Fasting glucose and HbA1c only become abnormal after years of progressive insulin resistance. Fasting insulin is elevated years earlier. Most men with metabolic syndrome have never had their insulin tested. |
| Homocysteine | ❌ No | One of the strongest modifiable cardiovascular and dementia risk factors — and easily corrected with methylated B vitamins. Almost never included in standard panels despite decades of supporting evidence. |
| IGF-1 | ❌ No | Tells you how your cellular repair and regeneration machinery is functioning — the growth hormone axis. Declining IGF-1 is a primary driver of frailty and accelerated aging that standard physicals completely overlook. |
| DHEA-S | ❌ Rarely | One of the most reliable hormonal aging markers available. Tracks adrenal reserve, stress resilience, and overall hormonal vitality. Never included in standard panels despite strong evidence for its clinical utility. |
| Omega-3 Index | ❌ Never | Direct measurement of cell membrane health and one of the strongest modifiable predictors of cardiovascular mortality. Zero standard physical panels include it. Easily correctable with targeted supplementation. |
| Vitamin D (25-OH) | ⚠️ Sometimes — only if requested | Deficiency affects an estimated 40–60% of American adults and is linked to accelerated aging, immune dysfunction, depression, and elevated all-cause mortality. Often only ordered after a specific complaint rather than as preventive screening. |
| Free T3 (Thyroid) | ❌ Rarely — TSH only | TSH alone misses subclinical hypothyroidism driven by poor T4-to-T3 conversion. A man can have a normal TSH and severely impaired thyroid function at the cellular level. Free T3 is the active hormone. |
The pattern is consistent: the standard annual physical is built around population-level disease detection thresholds, not individual optimization. The biomarkers it misses are not obscure research markers — they are well-validated, clinically actionable tests with strong evidence bases. They are missing because standard care has not yet integrated the shift from disease management to proactive longevity optimization that defines the next generation of preventive medicine.
How to Get Tested: Panel Options and What They Cost
Not every man needs the most comprehensive panel immediately. Here is a practical framework for choosing the right level of testing based on where you are in your health journey:
| PANEL TIER | WHAT IT INCLUDES | WHO IT'S FOR | ESTIMATED COST |
|---|---|---|---|
| Standard Annual Physical | CBC, basic metabolic panel, lipid panel, fasting glucose, TSH. Usually ordered by a GP at the annual physical. | Baseline screening — useful but misses most longevity-critical markers | $0–$50 with insurance; $80–$200 out of pocket |
| Enhanced Men's Health Panel | All standard labs + free and total testosterone, PSA, HbA1c, vitamin D, ferritin, hs-CRP. Good step up from standard. | Men 40+ wanting to understand hormonal and basic metabolic health beyond standard screening | $150–$400 via direct-access labs; $300–$600 through clinic |
| Longevity Optimization Panel (Recommended) | All 12 biomarkers in this article plus SHBG, estradiol, LH/FSH, ApoB, homocysteine, fasting insulin, DHEA-S, IGF-1, omega-3 index, cortisol. Full picture. | Men 40+ serious about understanding their aging trajectory and identifying every modifiable risk factor | $200–$500 via direct-access labs (Ulta Lab Tests, Walk-In Lab); $400–$800 through specialist clinic |
| Advanced Biological Age Panel | Longevity panel + epigenetic age testing (DunedinPACE or GrimAge), advanced cardiovascular markers (Lp(a), oxidized LDL), full gut microbiome panel, continuous glucose monitoring. | Men who want the most comprehensive available picture of biological aging for proactive optimization | $800–$2,500 depending on tests included; specialist interpretation recommended |
The Most Practical Starting Point for Most Men Over 40
The Longevity Optimization Panel — which covers all 12 biomarkers in this article plus the full hormonal context — is the recommended starting point for any man over 40 who is serious about understanding his aging trajectory. Direct-access lab services like Ulta Lab Tests, Walk-In Lab, and LabCorp's patient-access program allow you to order this panel without a physician's order at $200 to $500. Ordering through a specialist longevity clinic adds cost but includes physician interpretation — which is where the data becomes genuinely useful rather than just a stack of numbers.
How to Actually Use Your Results: From Data to Action
A longevity blood panel without clinical interpretation is just a list of numbers with reference ranges. The value comes from understanding what the numbers mean in the context of your specific situation — and translating that understanding into targeted, prioritized interventions.
Prioritize by Impact and Modifiability
Not all out-of-range results are equal. The first pass through your results should identify which markers are furthest from optimal, which have the strongest evidence for downstream health impact, and which are most modifiable with available interventions. Elevated homocysteine with a clear B vitamin deficiency is a high-priority, highly modifiable finding with a simple, low-cost solution. Chronically elevated hs-CRP with no identified inflammatory driver is a high-priority finding that requires a more systematic investigation of root causes.
Look for Clusters, Not Isolated Findings
The most clinically meaningful findings often emerge from the pattern across multiple markers rather than from any single value. Elevated fasting insulin alongside elevated HbA1c, elevated hs-CRP, low testosterone, and abdominal fat accumulation is not five separate problems. It is a single metabolic syndrome picture with interrelated drivers that respond to a coherent set of interventions. Treating each marker in isolation misses the systemic nature of the problem.
Establish a Baseline and Track Trajectory
A single blood draw is a snapshot. Two draws a year apart are a trajectory. The most powerful use of longevity biomarker testing is longitudinal — establishing where you are now, implementing targeted interventions, and measuring whether those interventions are moving the markers in the right direction. This is the approach that separates proactive health optimization from the reactive model of waiting for a diagnosis and then treating the disease.
Work With a Physician Who Understands Optimization, Not Just Disease
Many of the interventions suggested by a longevity panel — hormone optimization, targeted supplementation, metabolic management — are outside the standard scope of primary care practice as it currently operates. A physician trained primarily in disease management may not know what to do with a free testosterone of 7 pg/mL, a DHEA-S in the bottom quartile for age, and an omega-3 index of 3.8 percent that are all individually 'within range.' This is why specialist longevity clinics and men's health programs that approach these results through an optimization lens — rather than a disease-detection framework — produce meaningfully different clinical guidance.
Frequently Asked Questions
Q: What blood tests should a man over 40 get annually?
At minimum, a man over 40 should have annual testing that goes beyond a standard physical panel to include: free and total testosterone, SHBG and estradiol, hs-CRP, HbA1c and fasting insulin, ApoB, homocysteine, free T3 and TSH, vitamin D (25-OH), DHEA-S, IGF-1, ferritin, and an omega-3 index. This panel — the longevity optimization panel described in this article — covers the major biological aging pathways and identifies the modifiable risk factors most likely to affect long-term health outcomes for men in this age group.
Q: What is the difference between a longevity blood panel and a standard physical?
A standard annual physical blood panel is designed to detect established disease — it will catch diabetes, flagrant thyroid dysfunction, and obvious cardiovascular risk, but only after these conditions have been developing for years. A longevity blood panel tests the underlying biological mechanisms of aging and disease before clinical thresholds are reached: insulin resistance before glucose is elevated, vascular risk through ApoB rather than just LDL, hormonal decline through free testosterone and DHEA-S rather than waiting for symptoms to become severe. The goal is identification and correction while trajectories are still changeable.
Q: What is the most important blood test for men over 40?
If forced to choose a single most important marker for men over 40, free testosterone is the strongest candidate — not because it is the most predictive of any single outcome, but because it influences the widest range of downstream health parameters: metabolic function, cardiovascular risk, cognitive performance, body composition, bone density, and psychological wellbeing. Testosterone optimization alone can move multiple other markers in the right direction. That said, hs-CRP and ApoB are close seconds for their direct cardiovascular risk relevance.
Q: How often should I get longevity blood work done?
For a comprehensive longevity panel, annually is the appropriate frequency for most men — long enough to allow interventions to produce measurable effects, frequent enough to catch unfavorable trajectories before they become clinical problems. For specific markers being actively managed — testosterone levels during TRT titration, vitamin D after starting supplementation, HbA1c during dietary intervention — retesting every 3 to 4 months is appropriate until the target range is reached, then returning to annual monitoring.
Q: Can I order longevity blood tests without a doctor?
Yes. Direct-access lab services — including Ulta Lab Tests, Walk-In Lab, and LabCorp's patient-direct program — allow individuals to order their own blood panels without a physician's order in most US states. This makes a comprehensive longevity panel accessible and significantly more affordable than ordering through a clinic's lab billing. The limitation of this approach is interpretation: having the numbers is only half the value. Working with a physician who can interpret the results in the context of your symptoms, history, and goals is what translates the data into actionable clinical guidance.
Q: What should I do if my results show multiple markers out of optimal range?
The appropriate response to multiple out-of-range longevity markers is not alarm — it is a systematic, prioritized clinical evaluation. Most men who run a longevity panel for the first time find several markers that are non-optimal. This is expected and is precisely why the testing has value. Work with a physician experienced in longevity optimization to identify the most impactful interventions, address underlying root causes rather than chasing individual numbers, and establish a monitoring plan to track whether interventions are working. The goal is trajectory correction, not achieving perfect numbers in a single testing cycle.
The Bottom Line
The biology of aging is not a mystery. It is a set of measurable, trackable, and in many cases highly modifiable processes that show up in the blood years before they become the diseases that eventually require treatment. The biomarkers in this panel are not exotic research tests — they are well-validated clinical markers that reflect the actual mechanisms driving cardiovascular disease, metabolic dysfunction, hormonal decline, cognitive aging, and all-cause mortality in men over 40.
The gap between knowing your numbers and not knowing them is the gap between proactive health management and reactive disease treatment. And the gap between knowing your standard lab numbers and knowing your longevity optimization numbers is the gap between population-average health and the kind of biological optimization that meaningfully changes what the next 20, 30, or 40 years of your life look like.
Your annual physical is not enough. It was not designed to be. A properly structured longevity panel — reviewed by a physician who understands what optimal means rather than just what is 'normal' — is the starting point for understanding where your biology actually is and what targeted interventions have the best evidence for improving where it is going.
References & Further Reading
- Bhasin S, et al. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.
- Ridker PM. (2016). From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection. Circulation Research.
- Sniderman AD, et al. (2019). A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk. Circulation: Cardiovascular Quality and Outcomes.
- Selhub J. (1999). Homocysteine Metabolism. Annual Review of Nutrition.
- Smith AD, et al. (2010). Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment. PLOS ONE.
- Holick MF. (2007). Vitamin D Deficiency. New England Journal of Medicine.
- Harris WS, et al. (2017). Erythrocyte Long-Chain Omega-3 Fatty Acid Levels Are Inversely Associated with Mortality and with Incident Cardiovascular Disease. Journal of Clinical Lipidology.
- Vigen R, et al. (2013). Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels. JAMA.
- Maggio M, et al. (2013). DHEA and Cognitive Function in the Elderly. Journal of Steroid Biochemistry and Molecular Biology.
- Levine ME, et al. (2018). An Epigenetic Biomarker of Aging for Lifespan and Healthspan. Aging (Albany NY).